The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...

Deborah Telman, Gilead Sciences Inc.'s top lawyer for the past three years, is relinquishing her duties as general counsel ...

The powerful new documentary special “Living Proof” will premiere on Hulu on Dec. 1 in honor of World AIDS Day. The ...

Buying $1000 In GILD: If an investor had bought $1000 of GILD stock 5 years ago, it would be worth $2,134.58 today based on a price of $128.61 for GILD at the time of writing.

Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

Bulevirtide proved to be effective up to 72 weeks in patients with chronic hepatitis D virus infection, regardless of whether ...

Aspen Neuroscience’s cash reserves have been fertilized with a $115 million series C fundraise that will enrich the biotech’s ...

Trouble sleeping? Feeling irritable or bloated? A new study suggests masturbating might help you through the menopause.

Ossium Health, a bioengineering company dedicated to improving human health through its organ donor bone marrow banking platform, announced today that Dr. Susannah Cantrell, PhD, has joined its ...